Presidio Pharmaceuticals' Series D Round

Presidio Pharmaceuticals raised a round of funding on June 16, 2014.

Presidio Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics. Presidio's focus is on effective therapies for …

Articles about Presidio Pharmaceuticals' Series D Round: